A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia

The interaction of acute myeloid leukemia (AML) blasts with the leukemic microenvironment is postulated to be an important mediator of resistance to chemotherapy and disease relapse. We hypothesized that inhibition of the CXCR4/CXCL12 axis by the small molecule inhibitor, plerixafor, would disrupt t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Uy, Geoffrey L., Rettig, Michael P., Motabi, Ibraheem H., McFarland, Kyle, Trinkaus, Kathryn M., Hladnik, Lindsay M., Kulkarni, Shashikant, Abboud, Camille N., Cashen, Amanda F., Stockerl-Goldstein, Keith E., Vij, Ravi, Westervelt, Peter, DiPersio, John F.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2012
Konular:
Clinical Trials and Observations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3350358/
https://ncbi.nlm.nih.gov/pubmed/22308295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-10-383406
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller